{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T01:35:41Z","timestamp":1790732141633,"version":"4.1.0"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31772014"],"award-info":[{"award-number":["31772014"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31471577"],"award-info":[{"award-number":["31471577"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005090","name":"Beijing Nova Program","doi-asserted-by":"publisher","award":["Z181100006218071"],"award-info":[{"award-number":["Z181100006218071"]}],"id":[{"id":"10.13039\/501100005090","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009592","name":"Beijing Municipal Science and Technology Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009592","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1016\/j.jconrel.2019.06.023","type":"journal-article","created":{"date-parts":[[2019,6,22]],"date-time":"2019-06-22T01:32:17Z","timestamp":1561167137000},"page":"139-149","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":103,"special_numbering":"C","title":["The hepatic-targeted, resveratrol loaded nanoparticles for relief of high fat diet-induced nonalcoholic fatty liver disease"],"prefix":"10.1016","volume":"307","author":[{"given":"Wendi","family":"Teng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liyun","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Songtao","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengying","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meiyu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junhua","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Bao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3245-3210","authenticated-orcid":false,"given":"Yuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fazheng","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2019.06.023_bb0005","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.cmet.2014.09.005","article-title":"Periostin: a new extracellular regulator of obesity-induced hepatosteatosis","volume":"20","author":"Wu","year":"2014","journal-title":"Cell Metab."},{"key":"10.1016\/j.jconrel.2019.06.023_bb0010","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.beem.2016.06.006","article-title":"Non-alcoholic fatty liver disease and risk of type 2 diabetes","volume":"30","author":"Lallukka","year":"2016","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jconrel.2019.06.023_bb0015","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.cmet.2017.08.002","article-title":"Nonalcoholic fatty liver disease as a Nexus of metabolic and hepatic diseases","volume":"27","author":"Samuel","year":"2017","journal-title":"Cell Metab."},{"key":"10.1016\/j.jconrel.2019.06.023_bb0020","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1016\/j.cgh.2012.10.001","article-title":"Association between nonalcoholic fatty liver disease and risk for hepatocellular cancer, based on systematic review","volume":"10","author":"White","year":"2012","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"10.1016\/j.jconrel.2019.06.023_bb0025","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1002\/hep.20466","article-title":"Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity","volume":"40","author":"Browning","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.jconrel.2019.06.023_bb0030","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1038\/nature13478","article-title":"The role of hepatic lipids in hepatic insulin resistance and type 2 diabetes","volume":"510","author":"Perry","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2019.06.023_bb0035","doi-asserted-by":"crossref","first-page":"S65","DOI":"10.1016\/j.jhep.2015.02.041","article-title":"Current efforts and trends in the treatment of NASH","volume":"62","author":"Ratziu","year":"2015","journal-title":"J. Hepatol."},{"key":"10.1016\/j.jconrel.2019.06.023_bb0040","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.cell.2012.01.032","article-title":"Finding a target for resveratrol","volume":"148","author":"Tennen","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.jconrel.2019.06.023_bb0045","doi-asserted-by":"crossref","first-page":"797","DOI":"10.4103\/1735-1995.168405","article-title":"Resveratrol and liver: a systematic review","volume":"20","author":"Faghihzadeh","year":"2015","journal-title":"J. Res. Med. Sci."},{"key":"10.1016\/j.jconrel.2019.06.023_bb0050","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/j.cell.2006.11.013","article-title":"Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1\u03b1","volume":"127","author":"Lagouge","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.jconrel.2019.06.023_bb0055","first-page":"953","article-title":"Relationship between mechanisms, bioavailibility, and preclinical chemopreventive efficacy of resveratrol: a conundrum","volume":"12","author":"Gescher","year":"2003","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"10.1016\/j.jconrel.2019.06.023_bb0060","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.phymed.2012.12.012","article-title":"Pharmacokinetics, tissue distribution and excretion study of resveratrol and its prodrug 3,5,4\u2032-tri- O -acetylresveratrol in rats","volume":"20","author":"Liang","year":"2013","journal-title":"Phytomedicine"},{"key":"10.1016\/j.jconrel.2019.06.023_bb0065","doi-asserted-by":"crossref","first-page":"130","DOI":"10.3109\/10242422.2015.1053469","article-title":"Optimization of lipase-catalyzed synthesis of novel galactosyl ligands for selective targeting of liposomes to the asialoglycoprotein receptor","volume":"33","author":"Nie","year":"2015","journal-title":"Biocatal Biotransform."},{"key":"10.1016\/j.jconrel.2019.06.023_bb0070","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.2174\/0929866521666140626102429","article-title":"Physiological roles of asialoglycoprotein receptors (ASGPRs) variants and recent advances in hepatic-targeted delivery of therapeutic molecules via ASGPRs","volume":"21","author":"Hu","year":"2014","journal-title":"Protein Pept. Lett."},{"key":"10.1016\/j.jconrel.2019.06.023_bb0075","first-page":"7833","article-title":"Preparation and characterization of the Adriamycin-loaded amphiphilic chitosan nanoparticles and their application in the treatment of liver cancer","volume":"14","author":"Kou","year":"2017","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.jconrel.2019.06.023_bb0080","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s00262-012-1369-3","article-title":"Proposed mechanism of off-target toxicity for antibody-drug conjugates;driven by mannose receptor uptake","volume":"62","author":"Gorovits","year":"2013","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.jconrel.2019.06.023_bb0085","doi-asserted-by":"crossref","first-page":"231","DOI":"10.2165\/00003088-199631030-00006","article-title":"Pharmacokinetic rationale for chemotherapeutic drugs combined with intra-arterial degradable starch microspheres","volume":"31","author":"Johansson","year":"1996","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.jconrel.2019.06.023_bb0090","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.ijpharm.2018.06.019","article-title":"TEMPO-oxidized starch nanoassemblies of negligible toxicity compared with polyacylic acids for high performance anti-cancer therapy","volume":"547","author":"Jiang","year":"2018","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2019.06.023_bb0095","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.foodhyd.2015.05.036","article-title":"Controlled release of anthocyanins from oxidized konjac glucomannan microspheres stabilized by chitosan oligosaccharides","volume":"51","author":"Lu","year":"2015","journal-title":"Food Hydrocoll."},{"key":"10.1016\/j.jconrel.2019.06.023_bb0100","doi-asserted-by":"crossref","first-page":"8669","DOI":"10.1021\/acs.jafc.5b03575","article-title":"Intestine-specific delivery of hydrophobic bioactives from oxidized starch microspheres with an enhanced stability","volume":"63","author":"Wang","year":"2015","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.jconrel.2019.06.023_bb0105","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1021\/bm900337n","article-title":"Preparation and characterization of oxidized starch polymer microgels for encapsulation and controlled release of functional ingredients","volume":"10","author":"Li","year":"2009","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.jconrel.2019.06.023_bb0110","doi-asserted-by":"crossref","first-page":"3158","DOI":"10.1210\/en.2012-1406","article-title":"Hepatic Src homology phosphatase 2 regulates energy balance in mice","volume":"153","author":"Nagata","year":"2012","journal-title":"Endocrinology"},{"key":"10.1016\/j.jconrel.2019.06.023_bb0115","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1111\/dom.13324","article-title":"Resveratrol effect on patients with non-alcoholic fatty liver disease: a matter of dose and treatment length","volume":"20","author":"Fogacci","year":"2019","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.jconrel.2019.06.023_bb0120","article-title":"Resveratrol ameliorates fibrosis and inflammation in a mouse model of nonalcoholic steatohepatitis","volume":"25","author":"Kessoku","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jconrel.2019.06.023_bb0125","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1021\/nn900002m","article-title":"Impact of nanotechnology on drug delivery","volume":"3","author":"Farokhzad","year":"2009","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2019.06.023_bb0130","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1002\/hep.29643","article-title":"Targeted delivery of miR-199a-3p using self-assembled dipeptide nanoparticles efficiently reduces hepatocellular carcinoma","volume":"67","author":"Varshney","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.jconrel.2019.06.023_bb0135","doi-asserted-by":"crossref","first-page":"2490","DOI":"10.1194\/jlr.R025882","article-title":"AMP-activated protein kinase: an emerging drug target to regulate imbalances in lipid and carbohydrate metabolism to treat cardio-metabolic diseases","volume":"53","author":"Srivastava","year":"2012","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.jconrel.2019.06.023_bb0140","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.cmet.2011.03.009","article-title":"AMPK phosphorylates and inhibits SREBP activity to attenuate hepatic Steatosis and atherosclerosis in diet-induced insulin-resistant mice","volume":"13","author":"Li","year":"2011","journal-title":"Cell Metab."},{"key":"10.1016\/j.jconrel.2019.06.023_bb0145","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1099\/vir.0.83491-0","article-title":"Activation of sterol regulatory element-binding protein 1c and fatty acid synthase transcription by hepatitis C virus non-structural protein 2","volume":"89","author":"Oem","year":"2008","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.jconrel.2019.06.023_bb0150","doi-asserted-by":"crossref","first-page":"33959","DOI":"10.1074\/jbc.M110.122978","article-title":"SIRT1 deacetylates and inhibits SREBP-1C activity in regulation of hepatic lipid metabolism","volume":"285","author":"Ponugoti","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jconrel.2019.06.023_bb0155","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1172\/JCI0215001","article-title":"Leptin reverses insulin resistance and hepatic steatosis in patients with severe lipodystrophy","volume":"109","author":"Petersen","year":"2002","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jconrel.2019.06.023_bb0160","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.2337\/db16-0662","article-title":"Glucoraphanin ameliorates obesity and insulin resistance through adipose tissue browning and reduction of metabolic endotoxemia in mice","volume":"66","author":"Nagata","year":"2017","journal-title":"Diabetes"},{"key":"10.1016\/j.jconrel.2019.06.023_bb0165","doi-asserted-by":"crossref","DOI":"10.3390\/nu10111681","article-title":"Effects of (\u2212)-Epigallocatechin Gallate (EGCG) on energy expenditure and microglia-mediated hypothalamic inflammation in mice fed a high-fat diet","volume":"10","author":"Zhou","year":"2018","journal-title":"Nutrients"},{"key":"10.1016\/j.jconrel.2019.06.023_bb0170","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.1007\/s00125-012-2644-8","article-title":"Regulation of insulin sensitivity by serine\/threonine phosphorylation of insulin receptor substrate proteins IRS1 and IRS2","volume":"55","author":"Copps","year":"2012","journal-title":"Diabetologia"},{"key":"10.1016\/j.jconrel.2019.06.023_bb0175","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1074\/jbc.M101521200","article-title":"Phosphorylation of Ser307 in insulin receptor substrate-1 blocks interactions with the insulin receptor and inhibits insulin action","volume":"277","author":"Aguirre","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jconrel.2019.06.023_bb0180","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1002\/mnfr.200700437","article-title":"Epigallocatechin gallate (EGCG) attenuates high glucose-induced insulin signaling blockade in human hepG2 hepatoma cells","volume":"52","author":"Lin","year":"2010","journal-title":"Mol. Nutr. Food Res."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016836591930344X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016836591930344X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T00:38:15Z","timestamp":1777509495000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016836591930344X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":36,"alternative-id":["S016836591930344X"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2019.06.023","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2019,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The hepatic-targeted, resveratrol loaded nanoparticles for relief of high fat diet-induced nonalcoholic fatty liver disease","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2019.06.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}